Skip to main content
. 2019 Mar 18;17(5):4032–4038. doi: 10.3892/etm.2019.7408

Figure 4.

Figure 4.

miR-425-5p inhibitor suppresses HeLa cell viability. MTT assay was used to examine cell viability of HeLa cells following transfection with miR-425-5p inhibitor, inhibitor control, miR-425-5p inhibitor + AIFM1-siRNA or miR-425-5p inhibitor + control-siRNA. Data are presented as the mean ± standard deviation. **P<0.01 vs. control group; ##P<0.01 vs. inhibitor group. siRNA, small interfering RNA; control, untransfected HeLa cells; inhibitor control, HeLa cells transfected with inhibitor control; inhibitor, HeLa cells transfected with miR-425-5p inhibitor; inhibitor + control-siRNA, HeLa cells co-transfected with miR-425-5p inhibitor and control siRNA; inhibitor + siRNA, HeLa cells co-transfected with miR-425-5p inhibitor and AIFM1-siRNA.